mTOR is also among the effectors of the Wnt signaling pathway, Accelerated hepatic lipogenesis is commonly observed in a number of metabolic disorders, including insulin resistance, metabolic syndrome and T2D. The increase in lipogenesis is another mechanism by which HFD consumption leads to obesity and diabetes. ChREBP and SREBP-1c are two key transcription factors for genes that encode lipogenic enzymes. Very little is known about the effect of curcumin on hepatic lipogenesis, although a recent study showed that in adipocytes curcumin inhibits fatty acid synthase. We found that curcumin reduced liver weight and intra-hepatic lipid content. More importantly, dietary curcumin was shown to repress SREBP-1c and ChREBP expression. This, along with the repression of L-PK by curcumin and the in vitro ChREBP LUC reporter analysis, suggest that inhibition of ChREBP expression and function are among the mechanisms by which this dietary component prevents obesity and its associated metabolic defects. It should also be pointed out that curcumin can block cardiac hypertrophy and the implicated underlying mechanism was the repression of p300-HAT activity and hence the inhibition of p300 acetylation of certain transcription factors. ChREBP was found to require p300 or CBP as a co-factor in stimulating the expression of TxNIP. We found here that TxNIP protein and mRNA expression in curcumin fed mice was also reduced. It remains to be determined whether p300 inhibition is among the mechanisms by which curcumin reduces the expression of L-PK and other targets of ChREBP. Together, our observations confirm that curcumin improves insulin signaling, glucose disposal, and blocks obesity during HFD consumption. Our data confirm that in this chronic HFD feeding model, the function of curcumin is mediated via increasing the capability of the animals in anti-oxidative stress and attenuating inflammatory response in adipocytes. Furthermore, in mature adipocytes, this appears occur independent of Wnt activation as curcumin did not activate Wnt pathway components or Wnt downstream target genes. Finally, we revealed the repressive effect of curcumin on hepatic lipogeneis, associated with the inhibition of ChREBP and SREBP-1c expression. Further investigation is required to determine whether the repressive property of curcumin on p300/CBP is additionally involved in reducing hepatic lipogenesis. Thus, the development of curcumin as a therapy for obesity, insulin CHIR-99021 GSK-3 inhibitor resistance and T2D is supported. The elderly population forms a precarious group characterized by multimorbidity, frailty and polypharmacy, leading to more complex care. Studies have shown that elderly patients do not receive the care that is known to be appropriate for them. It is postulated that there is much room for improvement of the quality of care for this group. Efforts have been made to explore where, when and for which conditions quality deficiencies exist in order to know where improvements are needed. Measurement sets like HEDIS, with 75 measures across eight domains of care, have been developed to assist in assessing the quality of care. In addition criteria such as the Beers criteria were suggested to map the use of inappropriate medication for the elderly. The Assessing Care of Vulnerable Elders quality indicator set was developed in the year 2000 by Rand Healthcare.